FIACCHINI, MAURO
FIACCHINI, MAURO
Corso di malattie del sangue e degli organi emolinfopoietici
2020 Tura, Sante; Cavo, Michele; Zinzani, Pier Luigi; Broccoli, Alessandro, Argnani, Lisa, Fiacchini, Mauro
A risk prediction score for invasive mold disease in patients with hematological malignancies
2013 Stanzani M;Lewis RE;Fiacchini M;Ricci P;Tumietto F;Viale P;Ambretti S;Baccarani M;Cavo M;Vianelli N
JAK2 V617F mutation in essential thrombocythemia: correlation with clinical characteristics, response to therapy and long-term outcome in a cohort of 275 patients
2009 Palandri F; Ottaviani E; Salmi F; Catani L; Polverelli N; Fiacchini M; Martinelli G; Baccarani M; Vianelli N.
Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.
2009 Palandri F; Catani L; Testoni N; Ottaviani E; Polverelli N; Fiacchini M; De Vivo A; Salmi F; Lucchesi A; Baccarani M; Vianelli N.
Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma.
2009 Cavo M; Di Raimondo F; Zamagni E; Patriarca F; Tacchetti P; Casulli AF; Volpe S; Perrone G; Ledda A; Ceccolini M; Califano C; Bigazzi C; Offidani M; Stefani P; Ballerini F; Fiacchini M; de Vivo A; Brioli A; Tosi P; Baccarani M.
Resolution of a Pseudomonas aeruginosa outbreak in a hematology unit with the use of disposable sterile water filters.
2006 Vianelli N.; Giannini MB.; Quarti C.; Bucci Sabattini MA.; Fiacchini M.; de Vivo A.; Graldi P.; Galli S.; Nanetti A.; Baccarani M.; Ricci P.
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients
2005 Russo D; Malagola M; Vivo A; Fiacchini M; Martinelli G; Piccaluga PP; Damiani D; Candoni A; Michielutti A; Castelli M; Testoni N; Ottaviani E; Rondoni M; Pricolo G; Mazza P; Zuffa E; Zaccaria A; Raspadori D; Bocchia M; Lauria F; Bonini A; Avanzini P; Gugliotta L; Visani G; Fanin R; Baccarani M
Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission.
2004 BUONAMICI S; OTTAVIANI E; VISANI G; BONIFAZI F; FIACCHINI M; BACCARANI M.; MARTINELLI G.
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia
2001 Amabile M.; Giannini B.; Testoni N.; Montefusco V.; Rosti G.; Zardini C.; Terragna C.; Buonamici S.; Ottaviani E.; Soverini S.; Fiacchini M.; Bassi S.; De Vivo A.; Trabacchi E.; Saglio G.; Pane F.; Baccarani M.; Tura S.; Martinelii G.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Corso di malattie del sangue e degli organi emolinfopoietici | Tura, Sante; Cavo, Michele; Zinzani, Pier Luigi; Broccoli, Alessandro, Argnani, Lisa, Fiacchini, ...Mauro | 2020-01-01 | - | Società Editrice Esculapio srl | 2.01 Capitolo / saggio in libro | - |
| A risk prediction score for invasive mold disease in patients with hematological malignancies | Stanzani M;Lewis RE;Fiacchini M;Ricci P;Tumietto F;Viale P;Ambretti S;Baccarani M;Cavo M;Vianelli N | 2013-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | mold PREDICTION RULE.pdf |
| JAK2 V617F mutation in essential thrombocythemia: correlation with clinical characteristics, response to therapy and long-term outcome in a cohort of 275 patients | Palandri F; Ottaviani E; Salmi F; Catani L; Polverelli N; Fiacchini M; Martinelli G; Baccarani M;... Vianelli N. | 2009-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy. | Palandri F; Catani L; Testoni N; Ottaviani E; Polverelli N; Fiacchini M; De Vivo A; Salmi F; Lucc...hesi A; Baccarani M; Vianelli N. | 2009-01-01 | AMERICAN JOURNAL OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma. | Cavo M; Di Raimondo F; Zamagni E; Patriarca F; Tacchetti P; Casulli AF; Volpe S; Perrone G; Ledda... A; Ceccolini M; Califano C; Bigazzi C; Offidani M; Stefani P; Ballerini F; Fiacchini M; de Vivo A; Brioli A; Tosi P; Baccarani M. | 2009-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Resolution of a Pseudomonas aeruginosa outbreak in a hematology unit with the use of disposable sterile water filters. | Vianelli N.; Giannini MB.; Quarti C.; Bucci Sabattini MA.; Fiacchini M.; de Vivo A.; Graldi P.; G...alli S.; Nanetti A.; Baccarani M.; Ricci P. | 2006-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients | Russo D; Malagola M; Vivo A; Fiacchini M; Martinelli G; Piccaluga PP; Damiani D; Candoni A; Michi...elutti A; Castelli M; Testoni N; Ottaviani E; Rondoni M; Pricolo G; Mazza P; Zuffa E; Zaccaria A; Raspadori D; Bocchia M; Lauria F; Bonini A; Avanzini P; Gugliotta L; Visani G; Fanin R; Baccarani M | 2005-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission. | BUONAMICI S; OTTAVIANI E; VISANI G; BONIFAZI F; FIACCHINI M; BACCARANI M.; MARTINELLI G. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia | Amabile M.; Giannini B.; Testoni N.; Montefusco V.; Rosti G.; Zardini C.; Terragna C.; Buonamici ...S.; Ottaviani E.; Soverini S.; Fiacchini M.; Bassi S.; De Vivo A.; Trabacchi E.; Saglio G.; Pane F.; Baccarani M.; Tura S.; Martinelii G. | 2001-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |